Study of the S427G polymorphism and of MYBL2 variants in patients with acute myeloid leukemia

References

• Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999;18:3017–3033.
   PubMed Web of Science ®Google Scholar
• Fung SM, Ramsay G, Katzen AL. Mutations in Drosophila myb lead to centrosome amplification and genomic instability. Development 2002;129:347–359.
   PubMed Web of Science ®Google Scholar
• Garcia P, Frampton J. The transcription factor B-Myb is essential for S-phase progression and genomic stability in diploid and polyploidy megakaryocytes. J Cell Sci 2006;119:1483–1493.
   PubMed Web of Science ®Google Scholar
• Manak JR, Mitiku N, Lipsick JS. Mutation of the Drosophila homologue of the Myb protooncogene causes genomic instability. Proc Natl Acad Sci USA 2002;99:7438–7443.
   PubMed Web of Science ®Google Scholar
• Shepard JL, Amatruda JF, Stern HM, et al. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci USA 2005;102:13194–13199.
   PubMed Web of Science ®Google Scholar
• Tarasov KV, Tarasova YS, Tam WL, et al. B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS One 2008;3:e2478.
   PubMed Web of Science ®Google Scholar
• Lam EW, Bennett JD, Watson RJ. Cell-cycle regulation of human B-myb transcription. Gene1995;160:277–281.
   Google Scholar
• Lorvellec M, Dumon S, Maya-Mendoza A, et al. B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells. Stem Cells 2010;28:1751–1759.
   PubMed Web of Science ®Google Scholar
• Manak JR, Wen H, Van T, et al. Loss of Drosophila Myb interrupts the progression of chromosome condensation. Nat Cell Biol 2007;9: 581–587.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wu J, Li R, et al. B-MYB delays cell aging by repressing p16 (INK4alpha) transcription. Cell Mol Life Sci 2010;68:893–901.
   PubMed Web of Science ®Google Scholar
• Sala A. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer 2005;41:2479–2484.
   PubMed Web of Science ®Google Scholar
• Raschellà G, Cesi V, Amendola R, et al. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Cancer Res 1999;59:3365–3368.
   PubMed Web of Science ®Google Scholar
• Forozan F, Mahlamäki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000;60:4519–4525.
   PubMed Web of Science ®Google Scholar
• Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000;6:1833–1839.
   PubMed Web of Science ®Google Scholar
• Bar-Shira A, Pinthus JH, Rozovsky U, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002;62:6803–6807.
   PubMed Web of Science ®Google Scholar
• Zauli G, Voltan R, di Iasio MG, et al. miR-34a induces the down regulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin Cancer Res 2011;17:2712–2724.
   PubMed Web of Science ®Google Scholar
• Zondervan PE, Wink J, Alers JC, et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol 2000;192:207–215.
   PubMed Web of Science ®Google Scholar
• Mao X, Orchard G, Lillington DM, et al. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 2003;101:1513–1519.
   PubMed Web of Science ®Google Scholar
• Skotheim RI, Monni O, Mousses S, et al. New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 2002;62:2359–2364.
   PubMed Web of Science ®Google Scholar
• Raschellà G, Negroni A, Sala A, et al. Requirement of b-myb function for survival and differentiative potential of human neuroblastoma cells. J Biol Chem 1995;270:8540–8545.
   PubMed Web of Science ®Google Scholar
• Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817–2826.
   PubMed Web of Science ®Google Scholar
• Fuster O, Llop M, Dolz S, et al. Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients. Leuk Res 2013;37:1690–1696.
   PubMed Web of Science ®Google Scholar
• Schwab R, Bussolari R, Corvetta D, et al. Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk. Oncogene 2008;27:2929–2933.
   PubMed Web of Science ®Google Scholar
• Thorner AR, Hoadley KA, Parker JS, et al. In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene 2009;28: 742–751.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemias. French–American–British (FAB) co-operative group. Br J Haematol 1976;33:451–458.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–951.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–365.
   PubMed Web of Science ®Google Scholar
• Thiede C, Steudel C, Mohr B, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002;99:4326–4335.
   PubMed Web of Science ®Google Scholar
• Schnittger S, Schoch C, Kern W, et al. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 2005;106:3733–3739.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457–481.
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163–170.
   PubMedGoogle Scholar
• Shi H, Bevier M, Johansson R, et al. Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome. Breast Cancer Res Treat 2011;130:905–916.
   PubMed Web of Science ®Google Scholar
• Clarke M, Dumon S, Ward C, et al. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia. Leukemia 2013;27:661–670.
   PubMed Web of Science ®Google Scholar
• Golay J, Capucci A, Arsura M, et al. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 1991;77:149–158.
   PubMed Web of Science ®Google Scholar
• Reiss K, Travali S, Calabretta B, et al. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. J Cell Physiol 1991;148:338–343.
   PubMed Web of Science ®Google Scholar
• Engelhard A, Campbell K, Calabretta B. B-Myb alters the response of myeloid precursor cells to G-CSF. Exp Cell Res 2000;254: 153–162.
   PubMed Web of Science ®Google Scholar
• Martinez I, Cazalla D, Almstead LL, et al. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci USA 2011;108:522–527.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368:2059–2074.
   PubMed Web of Science ®Google Scholar